Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah A. Meadows
Sarah A. Meadows
Idelalisib
Chemistry
Progenitor cell
PI3K/AKT/mTOR pathway
Akt/PKB signaling pathway
3
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
2017
PLOS ONE
Anella Yahiaoui
Sarah A. Meadows
Rick Sorensen
Zhi-Hua Cui
Kathleen Keegan
Robert Brockett
Guang Chen
Christophe Queva
Li Li
Stacey Tannheimer
Show All
Source
Cite
Save
Citations (32)
PI3Kδ Inhibitor Idelalisib Inhibits AKT Signaling In Myelofibrosis Patients On Chronic JAK Inhibitor Therapy
2013
Blood
Sarah A. Meadows
Huong (Marie) Nguyen
Christophe Queva
Brian Lannutti
Adam Kashishian
Susie Jun
Steven Coutre
Roger Dansey
Jason Gotlib
Show All
Source
Cite
Save
Citations (3)
Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization
2007
Biochemistry
Sarah A. Meadows
Conrad Yap Edosada
Mark Mayeda
Thuy Thanh Tran
Clifford Quan
Helga Raab
Christian Wiesmann
Beni B. Wolf
Show All
Source
Cite
Save
Citations (21)
1